All Stories

  1. Self-reported risk factors for having Escherichia coli sequence type 131 or its H30 subclone among US Veterans with a clinical E. coli isolate

    Article • Epidemiology and Infection, December 2018, Cambridge University Press

    Professor James R. Johnson

  2. Prevalence and Molecular Characteristics of Clostridium difficile in Retail Meats, Food-Producing and Companion Animals, and Humans in Minnesota

    Article • Journal of Food Protection, September 2018, International Association for Food Protection

    Professor James R. Johnson

  3. Epidemic Emergence in the United States of Escherichia coli Sequence Type 131-H30 (ST131-H30), 2000 to 2009

    Article • Antimicrobial Agents and Chemotherapy, May 2017, ASM Journals

    Professor James R. Johnson

  4. Rapid and Specific Detection of the Escherichia coli Sequence Type 648 Complex within Phylogroup F

    Article • Journal of Clinical Microbiology, January 2017, ASM Journals

    Professor James R. Johnson

  5. Extraintestinal Pathogenic and Antimicrobial-Resistant Escherichia coli, Including Sequence Type 131 (ST131), from Retail Chicken Breasts in the United States in 2013

    Article • Applied and Environmental Microbiology, January 2017, ASM Journals

    Professor James R. Johnson

  6. Escherichia coli Sequence Type 131 H30 Is the Main Driver of Emerging Extended-Spectrum-β-Lactamase-Producing E. coli at a Tertiary Care Center

    Article • mSphere, November 2016, ASM Journals

    Professor James R. Johnson

  7. Environmental Contamination in Households of Patients with Recurrent Clostridium difficile Infection

    Article • Applied and Environmental Microbiology, February 2016, ASM Journals

    Professor James R. Johnson

  8. Activity of Eravacycline against Escherichia coli Clinical Isolates Collected from U.S. Veterans in 2011 in Relation to Coresistance Phenotype and Sequence Type 131 Genotype

    Article • Antimicrobial Agents and Chemotherapy, December 2015, ASM Journals

    Professor James R. Johnson

  9. Greater Ciprofloxacin Tolerance as a Possible Selectable Phenotype Underlying the Pandemic Spread of theH30 Subclone of Escherichia coli Sequence Type 131

    Article • Antimicrobial Agents and Chemotherapy, August 2015, ASM Journals

    Professor James R. Johnson

  10. Intensity and Mechanisms of Fluoroquinolone Resistance within theH30 andH30Rx Subclones of Escherichia coli Sequence Type 131 Compared with Other Fluoroquinolone-Resistant E. coli

    Article • Antimicrobial Agents and Chemotherapy, May 2015, ASM Journals

    Professor James R. Johnson

  11. Rapid and Specific Detection, Molecular Epidemiology, and Experimental Virulence of the O16 Subgroup within Escherichia coli Sequence Type 131

    Article • Journal of Clinical Microbiology, February 2014, ASM Journals

    Professor James R. Johnson

  12. Susceptibility to Alternative Oral Antimicrobial Agents in Relation to Sequence Type ST131 Status and Coresistance Phenotype among Recent Escherichia coli Isolates from U.S. Veterans

    Article • Antimicrobial Agents and Chemotherapy, July 2013, ASM Journals

    Professor James R. Johnson